Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
54
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Grogan Jane | Head of Research | 22 | $0 | $0 | 2026-10-30 |
| Godbout Sean | Chief Accounting Officer | 21 | $0 | $0 | 2026-10-02 |
| Parini Michael | Chief Legal Officer | 2 | $0 | $0 | 2026-09-01 |
| Minor Lloyd | Director | 6 | $0 | $479.5K | 2026-08-04 |
| Pangalos Menelas N | Director | 4 | $0 | $0 | 2026-06-09 |
| LANGER SUSAN | Director | 4 | $0 | $0 | 2026-06-09 |
| Patolawala Monish D | Director | 3 | $0 | $0 | 2026-06-09 |
| Mantas Jesus B | Director | 9 | $239.8K | $0 | 2026-06-09 |
| Freire Maria C | Director | 6 | $0 | $0 | 2026-06-09 |
| Rowinsky Eric K | Director | 35 | $101.3K | $12.63M | 2026-06-09 |
| HAWKINS WILLIAM A | Director | 8 | $0 | $0 | 2026-06-09 |
| SHERWIN STEPHEN A | Director | 46 | $0 | $9.89M | 2026-06-09 |
| Keeney Adam | Head of Corporate Development | 22 | $0 | $0 | 2026-05-01 |
| Murphy Nicole | Head of Pharm Ops and Tech | 78 | $585 | $0 | 2026-02-13 |
| Izzar Rachid | Head of Global Product Strat. | 76 | $0 | $300.1K | 2026-02-13 |
| Viehbacher Christopher | President and CEO | 18 | $0 | $0 | 2026-02-13 |
| Singhal Priya | Head of Development | 83 | $0 | $2.02M | 2026-02-13 |
| Kramer Robin | VP, Chief Accounting Officer | 116 | $0 | $0 | 2026-02-13 |
| Gregory Ginger | EVP, Human Resources | 120 | $0 | $2.49M | 2026-02-13 |
| ALEXANDER SUSAN H | EVP, General Counsel | 238 | $0 | $27.43M | 2026-02-13 |
| DORSA CAROLINE | Director | 26 | $151.6K | $12.15M | 2025-06-17 |
| MCDONNELL MICHAEL R | EVP, Chief Financial Officer | 61 | $0 | $0 | 2025-02-10 |
| Mulligan Richard | Director | 28 | $0 | $11.05M | 2022-06-15 |
| DENNER ALEXANDER J | Director | 44 | $176.85M | $10.94M | 2022-06-15 |
| JONES WILLIAM D /CA/ | Director | 2 | $0 | $0 | 2022-06-15 |
| PAPADOPOULOS STELIOS | Director | 25 | $3.05M | $8.48M | 2022-06-15 |
| Guindo Chirfi | Head of Glob Prod Strat & Com | 49 | $0 | $1.36M | 2022-02-18 |
| Vounatsos Michel | EVP & Chief Commercial Officer | 76 | $2.77M | $0 | 2022-02-18 |
| Galdes Alphonse | EVP Pharmaceutical Oper & Tech | 32 | $0 | $0 | 2022-01-19 |
| Posner Brian S | Director | 30 | $0 | $4.20M | 2021-07-01 |
| LEAMING NANCY | Director | 23 | $0 | $2.50M | 2021-07-01 |
| Sandrock Alfred | Head of Research & Development | 183 | $0 | $17.31M | 2021-06-07 |
| PANGIA ROBERT W | Director | 63 | $0 | $16.29M | 2020-06-03 |
| Karp Daniel | EVP, Corporate Development | 11 | $0 | $0 | 2020-02-12 |
| CAPELLO JEFFREY D | EVP & Chief Financial Officer | 16 | $0 | $0 | 2020-02-12 |
| SCHENK LYNN | Director | 20 | $0 | $3.69M | 2019-06-19 |
| Ehlers Michael D | EVP, Research and Development | 37 | $0 | $350.0K | 2019-06-01 |
| McKenzie Paul | EVP Pharmaceutical Oper & Tech | 34 | $0 | $0 | 2019-03-01 |
| COVINO GREGORY F | VP, Chief Accounting Officer | 75 | $0 | $0 | 2018-03-01 |
| Kress Jean-Paul | EVP Pres Int'l & Global Hd GTO | 1 | $0 | $0 | 2017-07-03 |
| Clancy Paul J | Executive VP and CFO | 126 | $0 | $46.01M | 2017-04-25 |
| Karaboutis Adriana | EVP, Tech. and Bus. Solutions | 37 | $0 | $447.3K | 2017-02-28 |
| DiPietro Kenneth | EVP Human Resources | 64 | $0 | $2.69M | 2017-02-28 |
| SCANGOS GEORGE A | Chief Executive Officer | 145 | $0 | $29.20M | 2016-07-21 |
| Koppel Adam | SVP, Chief Strategy Officer | 17 | $0 | $189.0K | 2016-06-06 |
| Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | 34 | $0 | $686.4K | 2016-04-02 |
| Cox John | EVP Pharmaceutical Oper & Tech | 71 | $0 | $5.39M | 2016-04-01 |
| Holtzman Steven H | EVP Corporate Development | 60 | $0 | $4.93M | 2016-02-23 |
| WILLIAMS DOUGLAS E | EVP Research & Development | 41 | $0 | $3.73M | 2015-06-19 |
| Kingsley Stuart A | EVP, Global Comm. Operations | 52 | $0 | $3.36M | 2015-02-23 |
| YOUNG WILLIAM | Director | 3 | $0 | $4.28M | 2014-01-08 |
| Pawlicki Raymond | SVP, Chief Information Officer | 27 | $0 | $5.32M | 2013-11-22 |
| Gagnon Robert E. | Vice President, Finance | 16 | $0 | $367.1K | 2012-02-29 |
| Granata Francesco | EVP Global Commercial Operatio | 3 | $0 | $0 | 2012-02-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Grogan Jane | Head of Research | M Exercise deriv | 2026-10-30 | 2026-11-02 | 695 | — | $0 | 0 | SEC↗ |
| Grogan Jane | Head of Research | F Tax w/h | 2026-10-30 | 2026-11-02 | 345 | $253.62 | $87.5K | 4,408 | SEC↗ |
| Grogan Jane | Head of Research | M Exercise | 2026-10-30 | 2026-11-02 | 695 | — | $0 | 4,753 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | M Exercise deriv | 2026-10-02 | 2026-10-05 | 27 | — | $0 | 0 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | F Tax w/h | 2026-10-02 | 2026-10-05 | 8 | $219.88 | $1.8K | 1,459 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | M Exercise | 2026-10-02 | 2026-10-05 | 27 | — | $0 | 1,467 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | A Award deriv | 2026-10-01 | 2026-10-05 | 985 | — | $0 | 985 | SEC↗ |
| Parini Michael | Chief Legal Officer | A Award deriv | 2026-09-01 | 2026-09-03 | 7,405 | — | $0 | 7,405 | SEC↗ |
| Parini Michael | Chief Legal Officer | A Award deriv | 2026-09-01 | 2026-09-03 | 7,405 | — | $0 | 7,405 | SEC↗ |
| Minor Lloyd | Director | S Sale | 2026-08-04 | 2026-08-05 | 593 | $200.96 | $119.2K | 2,689 | SEC↗ |
| Minor Lloyd | Director | S Sale | 2026-08-04 | 2026-08-05 | 593 | $200.96 | $119.2K | 2,689 | SEC↗ |
| Minor Lloyd | Director | S Sale | 2026-08-03 | 2026-08-05 | 593 | $203.34 | $120.6K | 3,282 | SEC↗ |
| Minor Lloyd | Director | S Sale | 2026-08-03 | 2026-08-05 | 593 | $203.34 | $120.6K | 3,282 | SEC↗ |
| Pangalos Menelas N | Director | M Exercise deriv | 2026-06-09 | 2026-06-11 | 2,370 | — | $0 | 0 | SEC↗ |
| Freire Maria C | Director | A Award | 2026-06-09 | 2026-06-11 | 2,005 | — | $0 | 8,820 | SEC↗ |
| Minor Lloyd | Director | A Award | 2026-06-09 | 2026-06-11 | 1,505 | — | $0 | 3,875 | SEC↗ |
| Pangalos Menelas N | Director | A Award | 2026-06-09 | 2026-06-11 | 1,505 | — | $0 | 3,875 | SEC↗ |
| Pangalos Menelas N | Director | M Exercise | 2026-06-09 | 2026-06-11 | 2,370 | — | $0 | 2,370 | SEC↗ |
| Patolawala Monish D | Director | A Award | 2026-06-09 | 2026-06-11 | 1,505 | — | $0 | 5,215 | SEC↗ |
| LANGER SUSAN | Director | A Award | 2026-06-09 | 2026-06-11 | 1,505 | — | $0 | 6,634 | SEC↗ |
| Mantas Jesus B | Director | A Award | 2026-06-09 | 2026-06-11 | 1,505 | — | $0 | 11,263 | SEC↗ |
| Rowinsky Eric K | Director | A Award | 2026-06-09 | 2026-06-11 | 1,505 | — | $0 | 25,844 | SEC↗ |
| SHERWIN STEPHEN A | Director | A Award | 2026-06-09 | 2026-06-11 | 1,505 | — | $0 | 15,193 | SEC↗ |
| HAWKINS WILLIAM A | Director | A Award | 2026-06-09 | 2026-06-11 | 1,505 | — | $0 | 10,365 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | M Exercise deriv | 2026-05-01 | 2026-05-05 | 939 | — | $0 | 0 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | F Tax w/h | 2026-05-01 | 2026-05-05 | 455 | $187.06 | $85.1K | 6,365 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | M Exercise | 2026-05-01 | 2026-05-05 | 939 | — | $0 | 6,820 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | M Exercise deriv | 2026-04-01 | 2026-04-03 | 181 | — | $0 | 364 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | M Exercise | 2026-04-01 | 2026-04-03 | 181 | — | $0 | 1,396 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | F Tax w/h | 2026-04-01 | 2026-04-03 | 54 | $183.78 | $9.9K | 1,342 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | A Award deriv | 2026-02-13 | 2026-02-17 | 8,450 | — | $0 | 8,450 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | A Award deriv | 2026-02-13 | 2026-02-17 | 1,800 | — | $0 | 1,800 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | A Award deriv | 2026-02-13 | 2026-02-17 | 8,025 | — | $0 | 8,025 | SEC↗ |
| Grogan Jane | Head of Research | A Award deriv | 2026-02-13 | 2026-02-17 | 8,450 | — | $0 | 8,450 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | A Award deriv | 2026-02-13 | 2026-02-17 | 7,390 | — | $0 | 7,390 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | A Award deriv | 2026-02-13 | 2026-02-17 | 8,025 | — | $0 | 8,025 | SEC↗ |
| Kramer Robin | Chief Financial Officer | A Award deriv | 2026-02-13 | 2026-02-17 | 8,450 | — | $0 | 8,450 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | A Award deriv | 2026-02-13 | 2026-02-17 | 10,560 | — | $0 | 10,560 | SEC↗ |
| Singhal Priya | Head of Development | A Award deriv | 2026-02-13 | 2026-02-17 | 10,560 | — | $0 | 10,560 | SEC↗ |
| Viehbacher Christopher | President and CEO | A Award deriv | 2026-02-13 | 2026-02-17 | 38,015 | — | $0 | 38,015 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | P Buy | 2026-02-12 | 2026-02-17 | 3 | $195.04 | $585 | 19,611 | SEC↗ |
| Singhal Priya | Head of Development | S Sale | 2026-02-09 | 2026-02-10 | 2,660 | $199.83 | $531.5K | 8,043 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | M Exercise deriv | 2026-02-06 | 2026-02-10 | 2,190 | — | $0 | 0 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | M Exercise deriv | 2026-02-06 | 2026-02-10 | 1,940 | — | $0 | 1,940 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | M Exercise deriv | 2026-02-06 | 2026-02-10 | 4,916 | — | $0 | 9,834 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | M Exercise deriv | 2026-02-06 | 2026-02-10 | 257 | — | $0 | 0 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | M Exercise deriv | 2026-02-06 | 2026-02-10 | 305 | — | $0 | 305 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | M Exercise deriv | 2026-02-06 | 2026-02-10 | 517 | — | $0 | 1,035 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | M Exercise deriv | 2026-02-06 | 2026-02-10 | 1,635 | — | $0 | 0 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | M Exercise deriv | 2026-02-06 | 2026-02-10 | 1,802 | — | $0 | 1,802 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | M Exercise deriv | 2026-02-06 | 2026-02-10 | 3,746 | — | $0 | 7,494 | SEC↗ |
| Grogan Jane | Head of Research | M Exercise deriv | 2026-02-06 | 2026-02-10 | 1,385 | — | $0 | 1,385 | SEC↗ |
| Grogan Jane | Head of Research | M Exercise deriv | 2026-02-06 | 2026-02-10 | 1,873 | — | $0 | 3,747 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | M Exercise deriv | 2026-02-06 | 2026-02-10 | 2,044 | — | $0 | 0 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | M Exercise deriv | 2026-02-06 | 2026-02-10 | 3,043 | — | $0 | 6,087 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | M Exercise deriv | 2026-02-06 | 2026-02-10 | 1,802 | — | $0 | 1,802 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | M Exercise deriv | 2026-02-06 | 2026-02-10 | 3,278 | — | $0 | 6,557 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | M Exercise deriv | 2026-02-06 | 2026-02-10 | 1,802 | — | $0 | 1,802 | SEC↗ |
| Kramer Robin | Chief Financial Officer | M Exercise deriv | 2026-02-06 | 2026-02-10 | 3,511 | — | $0 | 7,024 | SEC↗ |
| Kramer Robin | Chief Financial Officer | M Exercise deriv | 2026-02-06 | 2026-02-10 | 703 | — | $0 | 704 | SEC↗ |
| Kramer Robin | Chief Financial Officer | M Exercise deriv | 2026-02-06 | 2026-02-10 | 789 | — | $0 | 0 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise deriv | 2026-02-06 | 2026-02-10 | 4,683 | — | $0 | 9,367 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise deriv | 2026-02-06 | 2026-02-10 | 1,940 | — | $0 | 1,940 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise deriv | 2026-02-06 | 2026-02-10 | 2,102 | — | $0 | 0 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise deriv | 2026-02-06 | 2026-02-10 | 2,217 | — | $0 | 2,217 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise deriv | 2026-02-06 | 2026-02-10 | 4,683 | — | $0 | 9,367 | SEC↗ |
| Viehbacher Christopher | President and CEO | M Exercise deriv | 2026-02-06 | 2026-02-10 | 15,453 | — | $0 | 30,907 | SEC↗ |
| Viehbacher Christopher | President and CEO | M Exercise deriv | 2026-02-06 | 2026-02-10 | 9,008 | — | $0 | 9,009 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | M Exercise | 2026-02-06 | 2026-02-10 | 2,190 | — | $0 | 38,455 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | F Tax w/h | 2026-02-06 | 2026-02-10 | 1,059 | $201.18 | $213.0K | 37,396 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | M Exercise | 2026-02-06 | 2026-02-10 | 1,940 | — | $0 | 39,336 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | F Tax w/h | 2026-02-06 | 2026-02-10 | 931 | $201.18 | $187.3K | 38,405 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | F Tax w/h | 2026-02-06 | 2026-02-10 | 1,514 | $201.18 | $304.6K | 41,807 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | M Exercise | 2026-02-06 | 2026-02-10 | 4,916 | — | $0 | 43,321 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | M Exercise | 2026-02-06 | 2026-02-10 | 305 | — | $0 | 981 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | F Tax w/h | 2026-02-06 | 2026-02-10 | 180 | $201.18 | $36.2K | 1,215 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | M Exercise | 2026-02-06 | 2026-02-10 | 257 | — | $0 | 752 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | F Tax w/h | 2026-02-06 | 2026-02-10 | 76 | $201.18 | $15.3K | 676 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | F Tax w/h | 2026-02-06 | 2026-02-10 | 103 | $201.18 | $20.7K | 878 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | M Exercise | 2026-02-06 | 2026-02-10 | 517 | — | $0 | 1,395 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | F Tax w/h | 2026-02-06 | 2026-02-10 | 1,132 | $201.18 | $227.7K | 22,359 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | F Tax w/h | 2026-02-06 | 2026-02-10 | 666 | $201.18 | $134.0K | 19,745 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | M Exercise | 2026-02-06 | 2026-02-10 | 1,802 | — | $0 | 20,411 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | F Tax w/h | 2026-02-06 | 2026-02-10 | 791 | $201.18 | $159.1K | 18,609 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | M Exercise | 2026-02-06 | 2026-02-10 | 1,635 | — | $0 | 19,400 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | M Exercise | 2026-02-06 | 2026-02-10 | 3,746 | — | $0 | 23,491 | SEC↗ |
| Grogan Jane | Head of Research | M Exercise | 2026-02-06 | 2026-02-10 | 1,385 | — | $0 | 3,176 | SEC↗ |
| Grogan Jane | Head of Research | F Tax w/h | 2026-02-06 | 2026-02-10 | 407 | $201.18 | $81.9K | 2,769 | SEC↗ |
| Grogan Jane | Head of Research | M Exercise | 2026-02-06 | 2026-02-10 | 1,873 | — | $0 | 4,642 | SEC↗ |
| Grogan Jane | Head of Research | F Tax w/h | 2026-02-06 | 2026-02-10 | 584 | $201.18 | $117.5K | 4,058 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | M Exercise | 2026-02-06 | 2026-02-10 | 3,043 | — | $0 | 11,786 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | F Tax w/h | 2026-02-06 | 2026-02-10 | 775 | $201.18 | $155.9K | 11,011 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | F Tax w/h | 2026-02-06 | 2026-02-10 | 458 | $201.18 | $92.1K | 8,743 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | M Exercise | 2026-02-06 | 2026-02-10 | 1,802 | — | $0 | 9,201 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | F Tax w/h | 2026-02-06 | 2026-02-10 | 805 | $201.18 | $161.9K | 7,399 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | M Exercise | 2026-02-06 | 2026-02-10 | 2,044 | — | $0 | 8,204 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | F Tax w/h | 2026-02-06 | 2026-02-10 | 589 | $201.18 | $118.5K | 3,597 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | M Exercise | 2026-02-06 | 2026-02-10 | 1,802 | — | $0 | 4,186 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | M Exercise | 2026-02-06 | 2026-02-10 | 3,278 | — | $0 | 6,875 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | F Tax w/h | 2026-02-06 | 2026-02-10 | 994 | $201.18 | $200.0K | 5,881 | SEC↗ |
| Kramer Robin | Chief Financial Officer | F Tax w/h | 2026-02-06 | 2026-02-10 | 207 | $201.18 | $41.6K | 9,024 | SEC↗ |
| Kramer Robin | Chief Financial Officer | M Exercise | 2026-02-06 | 2026-02-10 | 789 | — | $0 | 8,801 | SEC↗ |
| Kramer Robin | Chief Financial Officer | F Tax w/h | 2026-02-06 | 2026-02-10 | 273 | $201.18 | $54.9K | 8,528 | SEC↗ |
| Kramer Robin | Chief Financial Officer | F Tax w/h | 2026-02-06 | 2026-02-10 | 1,063 | $201.18 | $213.9K | 11,472 | SEC↗ |
| Kramer Robin | Chief Financial Officer | M Exercise | 2026-02-06 | 2026-02-10 | 3,511 | — | $0 | 12,535 | SEC↗ |
| Kramer Robin | Chief Financial Officer | M Exercise | 2026-02-06 | 2026-02-10 | 703 | — | $0 | 9,231 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise | 2026-02-06 | 2026-02-10 | 4,683 | — | $0 | 21,016 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise | 2026-02-06 | 2026-02-10 | 2,102 | — | $0 | 16,324 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | F Tax w/h | 2026-02-06 | 2026-02-10 | 1,017 | $201.18 | $204.6K | 15,307 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise | 2026-02-06 | 2026-02-10 | 1,940 | — | $0 | 17,247 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | F Tax w/h | 2026-02-06 | 2026-02-10 | 914 | $201.18 | $183.9K | 16,333 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | F Tax w/h | 2026-02-06 | 2026-02-10 | 1,408 | $201.18 | $283.3K | 19,608 | SEC↗ |
| Singhal Priya | Head of Development | F Tax w/h | 2026-02-06 | 2026-02-10 | 1,056 | $201.18 | $212.4K | 7,432 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise | 2026-02-06 | 2026-02-10 | 4,683 | — | $0 | 12,115 | SEC↗ |
| Singhal Priya | Head of Development | F Tax w/h | 2026-02-06 | 2026-02-10 | 1,412 | $201.18 | $284.1K | 10,703 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise | 2026-02-06 | 2026-02-10 | 2,217 | — | $0 | 8,488 | SEC↗ |
| Viehbacher Christopher | President and CEO | F Tax w/h | 2026-02-06 | 2026-02-10 | 4,356 | $201.18 | $876.3K | 21,095 | SEC↗ |
| Viehbacher Christopher | President and CEO | M Exercise | 2026-02-06 | 2026-02-10 | 15,453 | — | $0 | 36,548 | SEC↗ |
| Viehbacher Christopher | President and CEO | F Tax w/h | 2026-02-06 | 2026-02-10 | 6,624 | $201.18 | $1.33M | 29,924 | SEC↗ |
| Viehbacher Christopher | President and CEO | M Exercise | 2026-02-06 | 2026-02-10 | 9,008 | — | $0 | 25,451 | SEC↗ |
| Singhal Priya | Head of Development | S Sale | 2026-02-02 | 2026-02-03 | 748 | $179.30 | $134.1K | 6,271 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise deriv | 2026-01-30 | 2026-02-03 | 1,829 | — | $0 | 0 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise | 2026-01-30 | 2026-02-03 | 1,829 | — | $0 | 7,601 | SEC↗ |
| Singhal Priya | Head of Development | F Tax w/h | 2026-01-30 | 2026-02-03 | 582 | $179.89 | $104.7K | 7,019 | SEC↗ |
| Viehbacher Christopher | President and CEO | M Exercise deriv | 2025-12-01 | 2025-12-03 | 7,040 | — | $0 | 0 | SEC↗ |
| Viehbacher Christopher | President and CEO | F Tax w/h | 2025-12-01 | 2025-12-03 | 3,404 | $177.78 | $605.2K | 16,443 | SEC↗ |
| Viehbacher Christopher | President and CEO | M Exercise | 2025-12-01 | 2025-12-03 | 7,040 | — | $0 | 19,847 | SEC↗ |
| Grogan Jane | Head of Research | M Exercise deriv | 2025-10-31 | 2025-11-04 | 695 | — | $0 | 695 | SEC↗ |
| Grogan Jane | Head of Research | F Tax w/h | 2025-10-31 | 2025-11-04 | 337 | $154.27 | $52.0K | 1,791 | SEC↗ |
| Grogan Jane | Head of Research | M Exercise | 2025-10-31 | 2025-11-04 | 695 | — | $0 | 2,128 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | M Exercise deriv | 2025-10-02 | 2025-10-06 | 26 | — | $0 | 27 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | F Tax w/h | 2025-10-02 | 2025-10-06 | 8 | $155.25 | $1.2K | 495 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | M Exercise | 2025-10-02 | 2025-10-06 | 26 | — | $0 | 503 | SEC↗ |
| Singhal Priya | Head of Development | S Sale | 2025-09-02 | 2025-09-02 | 517 | $133.55 | $69.0K | 5,772 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise deriv | 2025-08-29 | 2025-09-02 | 1,669 | — | $0 | 0 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise | 2025-08-29 | 2025-09-02 | 1,669 | — | $0 | 7,096 | SEC↗ |
| Singhal Priya | Head of Development | F Tax w/h | 2025-08-29 | 2025-09-02 | 807 | $132.22 | $106.7K | 6,289 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | S Sale | 2025-07-08 | 2025-07-16 | 2,223 | $135.00 | $300.1K | 6,330 | SEC↗ |
| Pangalos Menelas N | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 2,370 | — | $0 | 2,370 | SEC↗ |
| DORSA CAROLINE | Director | A Award | 2025-06-17 | 2025-06-18 | 3,160 | — | $0 | 31,002 | SEC↗ |
| LANGER SUSAN | Director | A Award | 2025-06-17 | 2025-06-18 | 2,370 | — | $0 | 5,129 | SEC↗ |
| SHERWIN STEPHEN A | Director | A Award | 2025-06-17 | 2025-06-18 | 2,370 | — | $0 | 13,688 | SEC↗ |
| Rowinsky Eric K | Director | A Award | 2025-06-17 | 2025-06-18 | 2,370 | — | $0 | 24,339 | SEC↗ |
| Freire Maria C | Director | A Award | 2025-06-17 | 2025-06-18 | 2,370 | — | $0 | 6,815 | SEC↗ |
| HAWKINS WILLIAM A | Director | A Award | 2025-06-17 | 2025-06-18 | 2,370 | — | $0 | 8,860 | SEC↗ |
| Mantas Jesus B | Director | A Award | 2025-06-17 | 2025-06-18 | 2,370 | — | $0 | 9,758 | SEC↗ |
| Patolawala Monish D | Director | A Award | 2025-06-17 | 2025-06-18 | 2,370 | — | $0 | 3,710 | SEC↗ |
| Minor Lloyd | Director | A Award | 2025-06-17 | 2025-06-18 | 2,370 | — | $0 | 2,370 | SEC↗ |
| Singhal Priya | Head of Development | S Sale | 2025-05-19 | 2025-05-20 | 3,806 | $126.25 | $480.5K | 5,427 | SEC↗ |
| DORSA CAROLINE | Director | P Buy | 2025-05-02 | 2025-05-05 | 1,235 | $122.72 | $151.6K | 27,842 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | M Exercise deriv | 2025-05-01 | 2025-05-05 | 938 | — | $0 | 939 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | M Exercise | 2025-05-01 | 2025-05-05 | 938 | — | $0 | 2,838 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | F Tax w/h | 2025-05-01 | 2025-05-05 | 454 | $120.93 | $54.9K | 2,384 | SEC↗ |
| Godbout Sean | Chief Accounting Officer | A Award deriv | 2025-04-01 | 2025-04-03 | 545 | — | $0 | 545 | SEC↗ |
| SHERWIN STEPHEN A | Director | S Sale | 2025-03-07 | 2025-03-10 | 8,760 | $150.02 | $1.31M | 11,318 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | M Exercise deriv | 2025-02-10 | 2025-02-12 | 1,515 | — | $0 | 0 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | M Exercise deriv | 2025-02-10 | 2025-02-12 | 2,575 | — | $0 | 0 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | M Exercise deriv | 2025-02-10 | 2025-02-12 | 2,159 | — | $0 | 0 | SEC↗ |
| Kramer Robin | Chief Accounting Officer | M Exercise deriv | 2025-02-10 | 2025-02-12 | 834 | — | $0 | 0 | SEC↗ |
| MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M Exercise deriv | 2025-02-10 | 2025-02-12 | 3,257 | — | $0 | 0 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise deriv | 2025-02-10 | 2025-02-12 | 2,272 | — | $0 | 0 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise deriv | 2025-02-10 | 2025-02-12 | 1,212 | — | $0 | 0 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | F Tax w/h | 2025-02-10 | 2025-02-12 | 445 | $142.54 | $63.4K | 8,553 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | M Exercise | 2025-02-10 | 2025-02-12 | 1,515 | — | $0 | 8,998 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | F Tax w/h | 2025-02-10 | 2025-02-12 | 807 | $142.54 | $115.0K | 36,265 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | M Exercise | 2025-02-10 | 2025-02-12 | 2,575 | — | $0 | 37,072 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | F Tax w/h | 2025-02-10 | 2025-02-12 | 634 | $142.54 | $90.4K | 17,598 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | M Exercise | 2025-02-10 | 2025-02-12 | 2,159 | — | $0 | 18,232 | SEC↗ |
| Kramer Robin | Chief Accounting Officer | F Tax w/h | 2025-02-10 | 2025-02-12 | 245 | $142.54 | $34.9K | 8,012 | SEC↗ |
| Kramer Robin | Chief Accounting Officer | M Exercise | 2025-02-10 | 2025-02-12 | 834 | — | $0 | 8,257 | SEC↗ |
| MCDONNELL MICHAEL R | EVP, Chief Financial Officer | F Tax w/h | 2025-02-10 | 2025-02-12 | 1,371 | $142.54 | $195.4K | 24,341 | SEC↗ |
| MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M Exercise | 2025-02-10 | 2025-02-12 | 3,257 | — | $0 | 25,712 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | F Tax w/h | 2025-02-10 | 2025-02-12 | 670 | $142.54 | $95.5K | 14,055 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise | 2025-02-10 | 2025-02-12 | 2,272 | — | $0 | 14,725 | SEC↗ |
| Singhal Priya | Head of Development | F Tax w/h | 2025-02-10 | 2025-02-12 | 357 | $142.54 | $50.9K | 9,066 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise | 2025-02-10 | 2025-02-12 | 1,212 | — | $0 | 9,423 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | M Exercise deriv | 2025-02-07 | 2025-02-10 | 2,190 | — | $0 | 2,190 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | M Exercise deriv | 2025-02-07 | 2025-02-10 | 1,940 | — | $0 | 3,880 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | M Exercise deriv | 2025-02-07 | 2025-02-10 | 1,801 | — | $0 | 3,604 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | M Exercise deriv | 2025-02-07 | 2025-02-10 | 1,635 | — | $0 | 1,635 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise deriv | 2025-02-07 | 2025-02-10 | 2,216 | — | $0 | 4,434 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise deriv | 2025-02-07 | 2025-02-10 | 1,940 | — | $0 | 3,880 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise deriv | 2025-02-07 | 2025-02-10 | 2,102 | — | $0 | 2,102 | SEC↗ |
| Kramer Robin | Chief Accounting Officer | M Exercise deriv | 2025-02-07 | 2025-02-10 | 703 | — | $0 | 1,407 | SEC↗ |
| Kramer Robin | Chief Accounting Officer | M Exercise deriv | 2025-02-07 | 2025-02-10 | 788 | — | $0 | 789 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | M Exercise deriv | 2025-02-07 | 2025-02-10 | 1,801 | — | $0 | 3,604 | SEC↗ |
| Grogan Jane | Head of Research | M Exercise deriv | 2025-02-07 | 2025-02-10 | 1,385 | — | $0 | 2,770 | SEC↗ |
| Viehbacher Christopher | President and CEO | M Exercise deriv | 2025-02-07 | 2025-02-10 | 9,008 | — | $0 | 18,017 | SEC↗ |
| MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M Exercise deriv | 2025-02-07 | 2025-02-10 | 2,216 | — | $0 | 4,434 | SEC↗ |
| MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M Exercise deriv | 2025-02-07 | 2025-02-10 | 2,335 | — | $0 | 2,335 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | M Exercise deriv | 2025-02-07 | 2025-02-11 | 2,043 | — | $0 | 2,044 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | M Exercise deriv | 2025-02-07 | 2025-02-11 | 1,801 | — | $0 | 3,604 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | F Tax w/h | 2025-02-07 | 2025-02-10 | 643 | $141.35 | $90.9K | 33,148 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | M Exercise | 2025-02-07 | 2025-02-10 | 1,940 | — | $0 | 35,088 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | F Tax w/h | 2025-02-07 | 2025-02-10 | 591 | $141.35 | $83.5K | 34,497 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | M Exercise | 2025-02-07 | 2025-02-10 | 2,190 | — | $0 | 33,791 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | M Exercise | 2025-02-07 | 2025-02-10 | 1,801 | — | $0 | 16,633 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | M Exercise | 2025-02-07 | 2025-02-10 | 1,635 | — | $0 | 15,312 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | F Tax w/h | 2025-02-07 | 2025-02-10 | 560 | $141.35 | $79.2K | 16,073 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | F Tax w/h | 2025-02-07 | 2025-02-10 | 480 | $141.35 | $67.8K | 14,832 | SEC↗ |
| Singhal Priya | Head of Development | F Tax w/h | 2025-02-07 | 2025-02-10 | 681 | $141.35 | $96.3K | 8,211 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise | 2025-02-07 | 2025-02-10 | 2,216 | — | $0 | 8,892 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | F Tax w/h | 2025-02-07 | 2025-02-10 | 620 | $141.35 | $87.6K | 11,116 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise | 2025-02-07 | 2025-02-10 | 1,940 | — | $0 | 13,056 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | F Tax w/h | 2025-02-07 | 2025-02-10 | 603 | $141.35 | $85.2K | 12,453 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise | 2025-02-07 | 2025-02-10 | 2,102 | — | $0 | 11,736 | SEC↗ |
| Kramer Robin | Chief Accounting Officer | M Exercise | 2025-02-07 | 2025-02-10 | 703 | — | $0 | 7,667 | SEC↗ |
| Kramer Robin | Chief Accounting Officer | F Tax w/h | 2025-02-07 | 2025-02-10 | 244 | $141.35 | $34.5K | 7,423 | SEC↗ |
| Kramer Robin | Chief Accounting Officer | M Exercise | 2025-02-07 | 2025-02-10 | 788 | — | $0 | 7,196 | SEC↗ |
| Kramer Robin | Chief Accounting Officer | F Tax w/h | 2025-02-07 | 2025-02-10 | 232 | $141.35 | $32.8K | 6,964 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | M Exercise | 2025-02-07 | 2025-02-10 | 1,801 | — | $0 | 2,463 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | F Tax w/h | 2025-02-07 | 2025-02-10 | 563 | $141.35 | $79.6K | 1,900 | SEC↗ |
| Grogan Jane | Head of Research | M Exercise | 2025-02-07 | 2025-02-10 | 1,385 | — | $0 | 1,876 | SEC↗ |
| Grogan Jane | Head of Research | F Tax w/h | 2025-02-07 | 2025-02-10 | 443 | $141.35 | $62.6K | 1,433 | SEC↗ |
| Viehbacher Christopher | President and CEO | M Exercise | 2025-02-07 | 2025-02-10 | 9,008 | — | $0 | 16,008 | SEC↗ |
| Viehbacher Christopher | President and CEO | F Tax w/h | 2025-02-07 | 2025-02-10 | 3,201 | $141.35 | $452.5K | 12,807 | SEC↗ |
| MCDONNELL MICHAEL R | EVP, Chief Financial Officer | F Tax w/h | 2025-02-07 | 2025-02-10 | 786 | $141.35 | $111.1K | 20,955 | SEC↗ |
| MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M Exercise | 2025-02-07 | 2025-02-10 | 2,216 | — | $0 | 23,171 | SEC↗ |
| MCDONNELL MICHAEL R | EVP, Chief Financial Officer | F Tax w/h | 2025-02-07 | 2025-02-10 | 716 | $141.35 | $101.2K | 22,455 | SEC↗ |
| MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M Exercise | 2025-02-07 | 2025-02-10 | 2,335 | — | $0 | 21,741 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | F Tax w/h | 2025-02-07 | 2025-02-11 | 565 | $141.35 | $79.9K | 6,059 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | M Exercise | 2025-02-07 | 2025-02-11 | 2,043 | — | $0 | 7,224 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | M Exercise | 2025-02-07 | 2025-02-11 | 1,801 | — | $0 | 7,860 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | F Tax w/h | 2025-02-07 | 2025-02-11 | 600 | $141.35 | $84.8K | 6,624 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | A Award deriv | 2025-02-06 | 2025-02-10 | 14,750 | — | $0 | 14,750 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | A Award deriv | 2025-02-06 | 2025-02-10 | 11,240 | — | $0 | 11,240 | SEC↗ |
| Singhal Priya | Head of Development | A Award deriv | 2025-02-06 | 2025-02-10 | 14,050 | — | $0 | 14,050 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | A Award deriv | 2025-02-06 | 2025-02-10 | 14,050 | — | $0 | 14,050 | SEC↗ |
| Kramer Robin | Chief Accounting Officer | A Award deriv | 2025-02-06 | 2025-02-10 | 10,535 | — | $0 | 10,535 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | A Award deriv | 2025-02-06 | 2025-02-10 | 9,130 | — | $0 | 9,130 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | A Award deriv | 2025-02-06 | 2025-02-10 | 9,835 | — | $0 | 9,835 | SEC↗ |
| Grogan Jane | Head of Research | A Award deriv | 2025-02-06 | 2025-02-10 | 5,620 | — | $0 | 5,620 | SEC↗ |
| Viehbacher Christopher | President and CEO | A Award deriv | 2025-02-06 | 2025-02-10 | 46,360 | — | $0 | 46,360 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise deriv | 2025-01-31 | 2025-02-03 | 1,828 | — | $0 | 1,829 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise | 2025-01-31 | 2025-02-03 | 1,828 | — | $0 | 7,254 | SEC↗ |
| Singhal Priya | Head of Development | F Tax w/h | 2025-01-31 | 2025-02-03 | 578 | $143.93 | $83.2K | 6,676 | SEC↗ |
| Singhal Priya | Head of Development | S Sale | 2024-12-09 | 2024-12-09 | 110 | $157.21 | $17.3K | 5,426 | SEC↗ |
| Kramer Robin | Chief Accounting Officer | M Exercise deriv | 2024-12-06 | 2024-12-09 | 351 | — | $0 | 0 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise deriv | 2024-12-06 | 2024-12-09 | 426 | — | $0 | 0 | SEC↗ |
| Kramer Robin | Chief Accounting Officer | M Exercise | 2024-12-06 | 2024-12-09 | 351 | — | $0 | 6,578 | SEC↗ |
| Kramer Robin | Chief Accounting Officer | F Tax w/h | 2024-12-06 | 2024-12-09 | 170 | $157.78 | $26.8K | 6,408 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise | 2024-12-06 | 2024-12-09 | 426 | — | $0 | 5,742 | SEC↗ |
| Singhal Priya | Head of Development | F Tax w/h | 2024-12-06 | 2024-12-09 | 206 | $157.78 | $32.5K | 5,536 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | G Gift | 2024-11-05 | 2024-11-07 | 20,082 | — | $0 | 20,082 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | G Gift | 2024-11-05 | 2024-11-07 | 20,082 | — | $0 | 31,601 | SEC↗ |
| Grogan Jane | Head of Research | M Exercise deriv | 2024-11-01 | 2024-11-04 | 695 | — | $0 | 1,390 | SEC↗ |
| Grogan Jane | Head of Research | F Tax w/h | 2024-11-01 | 2024-11-04 | 204 | $173.79 | $35.5K | 491 | SEC↗ |
| Grogan Jane | Head of Research | M Exercise | 2024-11-01 | 2024-11-04 | 695 | — | $0 | 695 | SEC↗ |
| Singhal Priya | Head of Development | S Sale | 2024-09-03 | 2024-09-05 | 431 | $204.22 | $88.0K | 5,316 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise deriv | 2024-08-30 | 2024-09-05 | 1,668 | — | $0 | 1,669 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise | 2024-08-30 | 2024-09-05 | 1,668 | — | $0 | 6,554 | SEC↗ |
| Singhal Priya | Head of Development | F Tax w/h | 2024-08-30 | 2024-09-05 | 807 | $204.76 | $165.2K | 5,747 | SEC↗ |
| DORSA CAROLINE | Director | A Award | 2024-06-21 | 2024-06-25 | 1,785 | — | $0 | 26,607 | SEC↗ |
| Freire Maria C | Director | A Award | 2024-06-21 | 2024-06-25 | 1,340 | — | $0 | 4,445 | SEC↗ |
| HAWKINS WILLIAM A | Director | A Award | 2024-06-21 | 2024-06-25 | 1,340 | — | $0 | 6,490 | SEC↗ |
| Patolawala Monish D | Director | A Award | 2024-06-21 | 2024-06-25 | 1,340 | — | $0 | 1,340 | SEC↗ |
| LANGER SUSAN | Director | A Award | 2024-06-21 | 2024-06-25 | 1,340 | — | $0 | 2,759 | SEC↗ |
| Rowinsky Eric K | Director | A Award | 2024-06-21 | 2024-06-25 | 1,340 | — | $0 | 21,969 | SEC↗ |
| Mantas Jesus B | Director | A Award | 2024-06-21 | 2024-06-25 | 1,340 | — | $0 | 7,388 | SEC↗ |
| SHERWIN STEPHEN A | Director | A Award | 2024-06-21 | 2024-06-25 | 1,340 | — | $0 | 20,078 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | M Exercise deriv | 2024-05-01 | 2024-05-03 | 938 | — | $0 | 1,877 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | F Tax w/h | 2024-05-01 | 2024-05-03 | 276 | $216.13 | $59.7K | 662 | SEC↗ |
| Keeney Adam | Head of Corporate Developmen | M Exercise | 2024-05-01 | 2024-05-03 | 938 | — | $0 | 938 | SEC↗ |
| Singhal Priya | Head of Development | S Sale | 2024-04-02 | 2024-04-03 | 93 | $213.09 | $19.8K | 4,886 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise deriv | 2024-04-01 | 2024-04-03 | 240 | — | $0 | 0 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | F Tax w/h | 2024-04-01 | 2024-04-03 | 117 | $214.83 | $25.1K | 9,634 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise | 2024-04-01 | 2024-04-03 | 240 | — | $0 | 9,751 | SEC↗ |
| Singhal Priya | Head of Development | S Sale | 2024-02-22 | 2024-02-26 | 262 | $221.23 | $58.0K | 4,886 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise deriv | 2024-02-16 | 2024-02-21 | 389 | — | $0 | 485 | SEC↗ |
| Singhal Priya | Head of Development | J Other deriv | 2024-02-16 | 2024-02-21 | 485 | — | $0 | 0 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise deriv | 2024-02-16 | 2024-02-21 | 819 | — | $0 | 0 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise deriv | 2024-02-16 | 2024-02-21 | 404 | — | $0 | 504 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | J Other deriv | 2024-02-16 | 2024-02-21 | 504 | — | $0 | 0 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise deriv | 2024-02-16 | 2024-02-21 | 856 | — | $0 | 0 | SEC↗ |
| MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M Exercise deriv | 2024-02-16 | 2024-02-21 | 2,152 | — | $0 | 2,684 | SEC↗ |
| MCDONNELL MICHAEL R | EVP, Chief Financial Officer | J Other deriv | 2024-02-16 | 2024-02-21 | 2,684 | — | $0 | 0 | SEC↗ |
| MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M Exercise deriv | 2024-02-16 | 2024-02-21 | 4,568 | — | $0 | 0 | SEC↗ |
| Kramer Robin | Chief Accounting Officer | M Exercise deriv | 2024-02-16 | 2024-02-21 | 431 | — | $0 | 537 | SEC↗ |
| Kramer Robin | Chief Accounting Officer | J Other deriv | 2024-02-16 | 2024-02-21 | 537 | — | $0 | 0 | SEC↗ |
| Kramer Robin | Chief Accounting Officer | M Exercise deriv | 2024-02-16 | 2024-02-21 | 914 | — | $0 | 0 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | J Other deriv | 2024-02-16 | 2024-02-21 | 807 | — | $0 | 0 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | M Exercise deriv | 2024-02-16 | 2024-02-21 | 647 | — | $0 | 807 | SEC↗ |
| Izzar Rachid | Head of Global Product Strat | M Exercise deriv | 2024-02-16 | 2024-02-21 | 1,370 | — | $0 | 0 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | M Exercise deriv | 2024-02-16 | 2024-02-21 | 1,507 | — | $0 | 1,879 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | J Other deriv | 2024-02-16 | 2024-02-21 | 1,879 | — | $0 | 0 | SEC↗ |
| Gregory Ginger | EVP, Human Resources | M Exercise deriv | 2024-02-16 | 2024-02-21 | 3,197 | — | $0 | 0 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | M Exercise deriv | 2024-02-16 | 2024-02-21 | 1,614 | — | $0 | 2,012 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | J Other deriv | 2024-02-16 | 2024-02-21 | 2,012 | — | $0 | 0 | SEC↗ |
| ALEXANDER SUSAN H | EVP Chief Legal Officer | M Exercise deriv | 2024-02-16 | 2024-02-21 | 3,423 | — | $0 | 0 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise | 2024-02-16 | 2024-02-21 | 389 | — | $0 | 5,429 | SEC↗ |
| Singhal Priya | Head of Development | F Tax w/h | 2024-02-16 | 2024-02-21 | 173 | $219.08 | $37.9K | 5,256 | SEC↗ |
| Singhal Priya | Head of Development | S Sale | 2024-02-16 | 2024-02-21 | 108 | $221.49 | $23.9K | 5,148 | SEC↗ |
| Singhal Priya | Head of Development | F Tax w/h | 2024-02-16 | 2024-02-21 | 295 | $219.08 | $64.6K | 5,040 | SEC↗ |
| Singhal Priya | Head of Development | M Exercise | 2024-02-16 | 2024-02-21 | 819 | — | $0 | 5,335 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | F Tax w/h | 2024-02-16 | 2024-02-21 | 414 | $219.08 | $90.7K | 9,210 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise | 2024-02-16 | 2024-02-21 | 404 | — | $0 | 9,614 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | F Tax w/h | 2024-02-16 | 2024-02-21 | 196 | $219.08 | $42.9K | 9,418 | SEC↗ |
| Murphy Nicole | Head of Pharm Ops and Tech | M Exercise | 2024-02-16 | 2024-02-21 | 856 | — | $0 | 9,624 | SEC↗ |
| MCDONNELL MICHAEL R | EVP, Chief Financial Officer | F Tax w/h | 2024-02-16 | 2024-02-21 | 2,337 | $219.08 | $512.0K | 18,355 | SEC↗ |
| MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M Exercise | 2024-02-16 | 2024-02-21 | 2,152 | — | $0 | 20,507 | SEC↗ |